Revolutionizing Early Detection:
AI for Pancreatic Cancer Screening

PancMD is on the leading edge of harnessing the power of artificial intelligence to detect
pancreatic cancer before it turns deadly.

Graph

Early detection of pancreatic cancer can increase
the survival rate from 7% to 42%.

Pancreatic Cancer:
A Critical Need for Early Detection

Pancreatic cancer is one of the most lethal forms of cancer, with a five-year survival rate of less than 10%. Early detection can drastically improve patient outcomes, but current screening methods are limited.

PancMD’s AI-powered technology offers a revolutionary solution, designed to detect the disease in its early stages, when treatment is most effective.

An AI Early Detection
Tool to Fight Cancer

PancMD is pioneering the use of artificial intelligence (AI) to identify subtle patterns and early indicators that traditional methods often miss.

Our proprietary algorithms analyze vast amounts of data from CT scans and medical data to pinpoint elevated risk factors in diabetes patients.

PancMD’s innovative application will empower healthcare providers with data-driven diagnostics, enabling earlier interventions to save lives.

AI Early Detection Image

Partnering to Save Lives:
Collaboration Opportunities for Healthcare Leaders

PancMD is seeking collaboration with visionary hospitals, research institutions, and healthcare networks to conduct clinical trials,
share anonymized data, and validate our AI solutions in real-world settings.

Our healthcare partners will be at the forefront of revolutionizing cancer detection technology,
helping us to bring this life-changing diagnostic methodology to the world.

Data Requests for Research

Securely share anonymized data to exponentially improve our AI models and aid in early detection research

Clinical Trials Participation

Join ground-breaking clinical trials that contribute to advancing early cancer detection technologies.

Invest in the Future of Healthcare Innovation


PancMD is at the intersection of pioneering AI technology and diagnostics for pancreatic cancer, one of the most challenging to diagnose and one of the most lethal. Our technology is ambitious and game-changing, with global market potential.

Investors who join our mission have the opportunity to advance a solution that will save lives and transform the landscape of cancer detection and treatment.

Investor Highlights
  • High-Growth Market Potential
  • Proven Technology with Successful Clinical Trials
  • Strong Partnerships with Healthcare Providers and Research Institutions
  • Experienced Leadership Team in AI and Oncology


News Feed


Unable to load RSS feed.
News Image 1
NUH AI interprets spinal stenosis in '47 seconds' and more AI briefs

Fri, 13 Sep 2024 02:50:46 -0400

Read More
News Image 1
Patients want healthcare's use of AI to be clear

Fri, 06 Sep 2024 11:03:03 -0400

Read More
News Image 1
EHR vendors still falling short on interoperability, data integration

Fri, 13 Sep 2024 12:01:24 -0400

Read More
News Image 1
Hong Kong conducts robotic telesurgery pilot with Switzerland

Mon, 09 Sep 2024 21:30:32 -0400

Read More
News Image 1
Epic calls on Carequality to release Particle dispute resolution

Mon, 30 Sep 2024 11:56:50 -0400

Read More
News Image 1
5G will power the next evolutionary stage of healthcare in APAC

Wed, 02 Oct 2024 06:46:58 -0400

Read More